A Small-Molecule Inhibitor of the Anthranilyl-CoA Synthetase PqsA for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa

Author:

Chen Jianwei1,Lu Yaojia1,Ye Fei2,Zhang Hongfang1,Zhou Yonglie3,Li Jiangtao4,Wu Qiang5,Xu Xuewei6,Wu Qihao1,Wei Bin1,Zhang Huawei1,Wang Hong1ORCID

Affiliation:

1. College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, China

2. College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China

3. Zhejiang Provincial People’s Hospital, Hangzhou, China

4. The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

5. State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China

6. Second Institute of Oceanography, MNR, Hangzhou, China

Abstract

Pseudomonas aeruginosa is a dominant hospital-acquired bacterial pathogen typically found in immunocompromised individuals. It is particularly dangerous for patients with chronic lung diseases and was identified as a serious threat for patients in the 2019 Antimicrobial Resistance Threats report ( https://www.cdc.gov/drugresistance/biggest-threats.html ).

Funder

National Natural Science Foundation of China

MOST | National Key Research and Development Program of China

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3